Kiromic BioPharma, Inc. (KRBP)
USD 1.1
(14.58%)
USD 1.1
(14.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -21.22 Million | -23.74 Million | -20.32 Million | -6.12 Million | -2.91 Million | -2.15 Million |
| Net Income | -20.94 Million | -34.73 Million | -25.58 Million | -19.2 Million | -3.72 Million | -3.81 Million |
| Depreciation & Amortization | 2.22 Million | 1.67 Million | 469.8 Thousand | 200 Thousand | 87.5 Thousand | 80.9 Thousand |
| Deferred income taxes | 5.03 Million | - | - | 22.2 Thousand | - | - |
| Stock-based compensation | 141.3 Thousand | 1.23 Million | 3.76 Million | 13.24 Million | 522.9 Thousand | 633 Thousand |
| Change in working capital | -3.21 Million | 4.36 Million | 710.3 Thousand | -394.5 Thousand | 183.1 Thousand | 315.8 Thousand |
| Other non-cash items | -4.45 Million | 3.7 Million | 324.2 Thousand | 200.00 | 20.5 Thousand | 633.1 Thousand |
| Investing Cash Flow | -206.6 Thousand | -4.86 Million | -1.81 Million | -1.45 Million | -302.7 Thousand | -137.3 Thousand |
| Investments in PPE | -206.6 Thousand | -4.88 Million | -1.89 Million | -1.45 Million | -302.7 Thousand | -137.3 Thousand |
| Acquisitions | - | 15 Thousand | 84 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -206.6 Thousand | 15 Thousand | -372 Thousand | - | - | - |
| Financing Cash Flow | 23.99 Million | 3.9 Million | 37.33 Million | 15.8 Million | 4.76 Million | 1.62 Million |
| Debt repayment | -557.2 Thousand | -508 Thousand | -573.7 Thousand | -188.1 Thousand | -250 Thousand | -725 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 659.1 Thousand | - | 40 Million | 15 Million | 4.51 Million | 900 Thousand |
| Other Financing Activities | 23.88 Million | 4.41 Million | -2.09 Million | 993.7 Thousand | - | 1.62 Million |
| Accounts receivables | - | 16.2 Thousand | 9800.00 | - | -78.8 Thousand | -18.9 Thousand |
| Accounts payables | -5.03 Million | 3.79 Million | 1.41 Million | -7700.00 | 293.4 Thousand | -4400.00 |
| Inventory | - | - | - | - | -5900.00 | - |
| Other working capital | 5.03 Million | 562.9 Thousand | -710.6 Thousand | -386.8 Thousand | -25.6 Thousand | 320.2 Thousand |
| Cash at beginning of period | 645.2 Thousand | 25.35 Million | 10.15 Million | 1.92 Million | 384.3 Thousand | 1.04 Million |
| Cash at end of period | 3.2 Million | 645.2 Thousand | 25.35 Million | 10.15 Million | 1.92 Million | 384.3 Thousand |
| Capital Expenditure | -206.6 Thousand | -4.88 Million | -1.89 Million | -1.45 Million | -302.7 Thousand | -137.3 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 2.55 Million | -24.7 Million | 15.2 Million | 8.22 Million | 1.54 Million | -665.2 Thousand |
| Free Cash Flow | -21.43 Million | -28.62 Million | -22.21 Million | -7.58 Million | -3.21 Million | -2.29 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.91 Million | -6.14 Million | -20.94 Million | -4.69 Million | -4.19 Million | -6.76 Million |
| Depreciation & Amortization | 557 Thousand | 557 Thousand | 2.22 Million | 555.6 Thousand | 560.1 Thousand | 549.6 Thousand |
| Deferred income taxes | - | - | 5.03 Million | - | - | - |
| Stock-based compensation | 29 Thousand | 57 Thousand | 141.3 Thousand | 58.8 Thousand | 26.4 Thousand | 35.4 Thousand |
| Change in working capital | -2.09 Million | -319 Thousand | -3.21 Million | -1.48 Million | -1.32 Million | -793.5 Thousand |
| Other non-cash items | 1.38 Million | 154 Thousand | -4.45 Million | 150.3 Thousand | -297.8 Thousand | 511.9 Thousand |
| Investing Cash Flow | -98 Thousand | -21 Thousand | -206.6 Thousand | -109.1 Thousand | -97.5 Thousand | - |
| Investments in PPE | -98 Thousand | -21 Thousand | -206.6 Thousand | -109.1 Thousand | -97.5 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 8.78 Million | 6.19 Million | 23.99 Million | 4.34 Million | 7 Million | 7.11 Million |
| Debt repayment | -8.78 Million | -6.19 Million | -557.2 Thousand | -57.5 Thousand | -170.1 Thousand | -166.5 Thousand |
| Dividends payments | -1.43 Million | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 659.1 Thousand | 659.1 Thousand | -27.9 Thousand | 877.4 Thousand |
| Other Financing Activities | - | 6.19 Million | 23.88 Million | 3.73 Million | 7.17 Million | 7.27 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 4000.00 | -147 Thousand | -5.03 Million | -2.15 Million | -1.54 Million | -2.18 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.1 Million | -172 Thousand | 5.03 Million | 669.6 Thousand | 219.9 Thousand | 1.39 Million |
| Cash at beginning of period | 3.67 Million | 3.2 Million | 645.2 Thousand | 4.37 Million | 2.7 Million | 2.05 Million |
| Cash at end of period | 4.17 Million | 3.67 Million | 3.2 Million | 3.2 Million | 4.37 Million | 2.7 Million |
| Capital Expenditure | -98 Thousand | -21 Thousand | -206.6 Thousand | -109.1 Thousand | -97.5 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 503 Thousand | 472 Thousand | 2.55 Million | -1.17 Million | 1.67 Million | 649.9 Thousand |
| Free Cash Flow | -8.27 Million | -5.72 Million | -21.43 Million | -5.51 Million | -5.32 Million | -6.46 Million |
MFDB
ILXP
RRRT
FTBYF
TGAFF
ANO